UNSPSC 51282915: Ecenofloxacin

This classification denotes a quinolone antibiotic with the molecular formula C19H21FN4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3613ZY362L, chemically known as 1,8-naphthyridine-3-carboxylic acid, 7-((1r,5s,6s)-6-amino-1-methyl-3-azabicyclo(3.2.0)hept-3-yl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-, rel-( )- but generally known as ecenofloxacin, which bears US NIH Compound Identifier 178066.

UNSPSC 51282915 Ecenofloxacin (Commodity) does not reflect state and local procurement activity in the recent opportunities on file. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC for Doxycycline Hyclate and Ciprofloxacin Hydrochloride, neither of which is ecenofloxacin; Seminole County, Florida solicited Naloxone and Safe Drug Deactivation Systems, also outside this code's nominal scope. The mismatch between the code name and the work actually tagged suggests the code sees limited or mis-tagged recent activity in state and local procurement.

No open solicitations under this Commodity code are currently posted in the available recent-opportunities block. The two most recent records—one a completed award to Chartwell Rx LLC and one a closed IFB from July 2023—do not represent active buying for ecenofloxacin or fluoroquinolone-class pharmaceuticals specifically. State and local procurement professionals evaluating this code should confirm whether relevant opportunities are tagged under a different UNSPSC classification or verify with issuing agencies whether ecenofloxacin procurement activity exists outside the current data set.